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 Abstract 
The number of opioid related overdose deaths has increased significantly over the past 
ten years. In order to combat this problem, many drug treatment programs have 
implemented Overdose Education and Naloxone Distribution programs as a harm 
reduction technique. While these programs are fairly new, initial research demonstrated 
effective reduction in the number of opioid overdose related deaths.  The risk of overdose 
deaths increases when an opioid addicted person is abstinent for a period of time and 
loses tolerance. Individuals who have been incarcerated, completed inpatient 
detoxification, or who have been admitted into an acute care setting  face the risk of 
losing tolerance as a result of being opiate-free for a period of time. This decrease in 
tolerance significantly increases the risk of overdose when they resume using opioids. 
The purpose of this program was to develop and implement an educational program on 
the epidemic of opioid overdose and the safe administration of Naloxone by lay people. 
This program was aimed at Registered Nurses working on an inpatient medical/surgical 
telemetry unit within a small, academic medical center. A needs assessment was 
performed and a 20 minute educational program was offered during a scheduled staff 
meeting. Pre and post surveys based on knowledge content were collected and results 
were analyzed. Program evaluation was conducted in order to define the strengths and 
weaknesses of the developed program. Conclusions and implications for APRN practice 
were presented to the organization’s Nurse Practice Council as well as Rhode Island 
College . 
Keywords: opioid overdose, opioid overdose education, harm reduction, 
Naloxone
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Overdose Education and Naloxone Distribution:  
Implementation in the Acute Care Setting  
Background/Statement of the Problem 
 Opioid- related overdose has become an epidemic in the United States.  In 2010, 
there were 38,329 drug overdose deaths; over 16,000 of those deaths were related to 
opioid analgesics (Centers for Disease Control and Prevention [CDC], 2014). In Rhode 
Island alone, there were 152 opioid related overdose deaths between November 2013 and 
March 2014 (CDC).  These startling statistics have gained media attention after respected 
celebrities, such as Philip Seymour-Hoffman, also became victim to the epidemic.  
 Statistics show that men are a greater risk to die from opioid overdose than 
women. The Veteran population, comprised of nearly 86 percent men, is at even greater 
risk than the general population because of the predisposing factors that they bring to the 
table. Some of these predisposing factors include war-related injuries leading to chronic 
pain and being exposed to trauma events. The high incidence of Post-Traumatic Stress 
Disorder (PTSD) amongst Veterans could be considered factorial in their rates of drug 
use. In fiscal year 2013, the Veteran’s Health Administration saw over 17,000 patients for 
opioid poisoning or other related encounters (United States Department of Veterans 
Affairs, 2014).  
 There are many myths surrounding opioid overdose. One of the most common 
myths is that heroin is the major player in the cause of overdose.  However, between 
1999-2009, the majority of drug overdose deaths involved opioid analgesics, 
Hydrocodone and Oxycodone being amongst the most prevalent (Bohnert et al., 2014). 
One must only quickly examine the top ten most prescribed medications in the United 
States to understand how this is occurring. Hydrocodone/Acetaminophen, also known as 
Vicodin, is represented three times in the top five most prescribed medications (Oliva, 
2013). However, this is not to say that heroin users are immune to overdose. The recent 
influx of Fentanyl-laced heroin has been another contributing factor in the major increase 
2	
 
in overdose deaths. Misuse of opioids of any kind can put an individual at risk. With an 
epidemic at hand, providers and clinicians had to act quickly to create a harm reduction 
strategy that could possibly save the lives of individuals who are at risk of overdose; 
prescribing Naloxone, an opioid antagonist or reversal agent, to high-risk individuals. In 
1996, community substance abuse programs began implementing Overdose Education 
and Naloxone Distribution (OEND) programs in an attempt to prevent opioid overdose-
related deaths. OEND programs involved training individuals identified as being high-
risk, how to recognize the signs and symptoms of opioid overdose and how to safely 
administer Naloxone in the event of a witnessed overdose. Preliminary program 
evaluations demonstrated that OEND programs were effective in reducing the number of 
deaths (Veterans Affairs Pharmacy and Benefits Management Services [VAPBM], 2014). 
Until recently, programs were scarce. It wasn’t until the rise in overdose deaths started to 
become more evident that OEND programs became more widespread. Since then, there 
has been a large push to make Naloxone accessible to those suffering from opioid 
addiction. Nationally, Opiate Treatment Programs provided education their patients in an 
attempt to keep their patients safe. 
Nurses are on the front lines of our healthcare system. Educating this population 
on the opioid overdose epidemic and increasing patients’ access to Naloxone has the 
potential to reach an even greater number of at-risk individuals. The purpose of this 
project was to develop and implement an educational program, “Opioid Overdose 
Education and Naloxone Distribution: Train the Trainer,” on the epidemic of opioid 
overdose and the safe administration of Naloxone by lay people such as, patients and 
their family members.  The program served to educate medical-surgical nurses on how to 
better identify patients at risk for opioid overdose once they are discharged from the 
hospital. It  also provided the nurses with the necessary knowledge to educate the patients 
and family members on how and when to administer Naloxone if they should experience 
or witness an overdose while in the community. 
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Next there will be a review of relevant literature.
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Literature Review 
 A comprehensive review of the literature was completed. Research from the years 
1996 to 2014 was extracted utilizing the search engines, CINHAL, Psych Info, and 
MEDLINE. The following key words were searched: opioid abuse, opioid overdose, 
overdose education, Naloxone, Naloxone distribution, peer education, and harm 
reduction. The following topic areas were discussed further: defining opioid overdose, 
harm reduction, Overdose Education and Naloxone Distribution Program: An Overview, 
overdose education and Naloxone distribution, and the Impact of Overdose Education 
and Naloxone Distribution programs. 
Defining Opioid Overdose 
 Opioids, sometimes referred to as narcotics, are substances used for pain relief. 
Opioids are naturally found from the opium poppy, but can also be produced 
synthetically for example: Heroin, Oxycodone, Vicodin, Fentanyl as well as others 
(Veterans Affairs Palo Alto Health Care System (VA PAHCS, 2013). These 
aforementioned substances can be obtained both licitly, prescribed by a physician for 
pain relief, or illicitly, through the diversion of prescribed medication or production and 
selling of heroin. Opioids can be ingested by mouth, intranasally, transdermally, or 
intravenously. Opioid overdose, also commonly referred to as opioid poisoning, opioid 
intoxication, or opioid toxicity, is defined as a condition caused by the ingestion or 
absorption of opioids (CDC, 2013).  Overdose from opioids occurs when there is too 
much drug for the body to handle. Overdose causes the brain to shut down the respiratory 
drive, which prevents the individual from breathing.  Overdose happens as a gradual 
process approximately 1-3 hours after the drug has been taken. (VA PAHCS). The 
condition of opioid overdose is described by a set a clinical symptoms. Symptoms are 
caused by depression of the central nervous system and respiratory drive and can include 
alteration in respiratory status, alteration in level of consciousness, and pinpoint pupils 
(National Institute for Health [NIH], 2013). Opioid overdose is further broken down into 
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cases of suspected, probable, or confirmed. Suspected overdose is defined as the 
evaluation of a patient by healthcare workers, which has not yet been supported by other 
credible evidence. Probable overdose occurs when there are high levels of suspicion, 
which can be connected with another case of overdose which has already been confirmed. 
Opioid overdose is classified as confirmed when both clinical evaluation and laboratory 
testing are consistent (CDC, 2014). 
Harm Reduction 
 Harm reduction, as defined by Tatarsky and Marlatt (2010), is a framework for 
addressing substance use and other potentially risky behaviors, which aims to reduce the 
harmful consequences of these behaviors without requiring abstinence as a goal or a 
prerequisite for treatment. The approach involves the acceptance that the individual may 
continue to use substances, but that the risks to the individual and the community are 
significantly decreased by implementing said harm reduction measures. Examples of 
harm reduction approaches include needle exchange programs for intravenous heroin 
users, medication assisted treatment programs for opiate addicts, and most recently, 
Naloxone distribution to the at-risk population. According to Tartarsky & Marlatt, harm 
reduction encompasses a “human rights agenda” (p.117) by providing treatment to 
marginalized populations and “is based on a deep appreciation of the uniqueness for each 
patient’s journey” (p.118). Harm reduction saw its origins in Europe in the 1970s and 
1980s. It was during the discovery of the HIV/AIDS epidemic that harm reduction made 
its way to the United States (Tartarsky & Marlatt, 2010).  
 Harm reduction is still considered to be widely controversial and often 
unsupported by the federal and state governments as well as many clinicians. Changes in 
governmental approach to the treatment of substance abusers have brought about more 
support of late. These changes include substance abuse treatment rather than 
incarceration, the recognition that substance abuse is often a comorbid condition with 
other mental health problems, and the push for evidence based practice (Tartarsky & 
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Marlatt). Marlatt, Larimer, & Witkiewitz (2012) suggested that harm reduction should 
not only protect the individual but should have more widespread effects such as changes 
in local policy and decriminalization at the local level. In 2012, the State of Rhode Island 
and Providence Plantations implemented the Rhode Island Good Samaritan Overdose 
Prevention Act. The act is a first-hand example of harm reduction strategies effecting 
local policy change. The act prevents any person who has called emergency services 
because of a witnessed drug overdose from facing criminal drug changes. Rhode Island is 
joined by 14 other states in enacting this type of legislation (Drug Policy Alliance, 2014). 
Overdose Education and Naloxone Distribution Programs: An Overview 
 Overdose Education and Naloxone Distribution programs first began in 1996 
within community based substance abuse harm reduction programs (VA Pharmacy 
Benefits and Management Services, 2014). In 2007, the year after Boston and Cambridge 
implemented OEND programs at local public health agencies, the Massachusetts 
Department of Public Health began to expand OEND offerings (Doe-Simkins et al., 
2014). Programs are now offered around the country in a variety of different settings.  
Some OEND programs provide teaching to drug users on an individual basis and others 
offer group education. Various curricula have been developed by agencies such as the 
Harm Reduction Coalition, the Chicago Recovery Alliance, and the Drug Overdose 
Prevention and Education project (Doe-Simkins et. al, 2014). The curriculums target 
substance abusers, physicians, and first-responders (Beletsky, Rich, & Walley, 2012). 
Some programs provide intramuscular Naloxone rescue kits, while others offer intranasal 
rescue kits (Wilder et al., 2014). Kits universally include two doses of Naloxone and 
educational instructions. Intramuscular kits usually include alcohol pads and gloves. 
Many programs also include face shields to provide rescue breathing (Doe-Simkins,       
et al.). Research has shown no significant difference in the effectiveness of intramuscular 
versus intranasal Naloxone, but there have been studies that show that intranasal 
Naloxone kits are more cumbersome and difficult for lay people to use. Intranasal 
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Naloxone sometimes requires additional doses, may have a slower onset of action, and 
may have lower bioavailability than intramuscular Naloxone (VA PBM, 2014). 
 A trained medical professional usually provides the educational offerings. Subject 
content includes how to recognize the signs and symptoms of opioid overdose, the 
importance of seeking help, the proper technique for rescue breathing, and the safe 
administration of Naloxone (Doe-Simkins, et al.). Participants receive education on how 
Naloxone works to reverse opioid overdose and instructions on if the individual has 
overdosed with long acting opiates, such as Fentanyl, an additional dose of Naloxone 
may be required as opioids typically have a longer half-life than Naloxone, so it is 
possible for individuals to fall back into an overdose as the Naloxone wears off. 
 Overdose Education and Naloxone Distribution programs have become more 
widespread throughout the United States in the face of the opioid overdose epidemic. 
While program content remains consistent amongst programs, methods for patient 
education vary. The route of Naloxone administration also varies amongst programs as 
provider preference or access to the medication contribute to which type of Naloxone the 
patients are given.  OEND programs have been shown to be effective in reversing opioid 
overdose and preventing overdose-related death (Oliva, 2014). 
Impact of Overdose Education and Naloxone Distribution 
 The majority of research on the effectiveness of OEND is currently measured 
through program evaluation. Because OEND has only recently become widespread, there 
are few systematic reviews available. However, initial research has shown that programs 
have been effective in reducing the number of fatal overdose deaths.  
 Walley et al (2013), sought to evaluate the OEND programs implemented in 
Massachusetts. The evaluation was done by performing a time series analysis of the 19 
communities that had implemented OEND. Researchers looked at fatal opioid overdose 
rates before and after OEND programs had been implemented as well as acute care 
hospital utilization rates for opioid overdose in each community. Results yielded 327 
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reversed opioid overdoses. The study also found that overdose rates had decreased 
approximately 73% (p<0.01) in the 19 studied Massachusetts’s communities and that 
OEND is an effective intervention in the face of the opioid overdose epidemic.  
 Williams, Marsden, and Strang (2013) sought to research the differences in 
knowledge and attitudes about opioid overdose in family members of heroin users. The 
study consisted of two groups, one receiving OEND training and one group that did not. 
Prior to the education, both groups reported similar knowledge and attitudes about opioid 
overdose. Following the intervention, the group who received OEND training not only 
had 35% of participants show increased knowledge about overdose, but 54% of 
participants also demonstrated more positive attitudes. Results also showed that the group 
who received OEND retained the information six months following the study. 
 Green, Heimer, and Grau (2008) were some of the first researchers to look at 
early OEND programs throughout the United States. They evaluated six programs around 
the country. Programs were based in Baltimore, San Francisco, Chicago, New York, and 
New Mexico. Ten participants (heroin users) from each site were recruited to complete a 
survey testing their knowledge of OEND. Participants were divided into groups of those 
who had been trained in OEND and those who had not. They were given 16 scenarios 
and asked whether an overdose was occurring and whether Naloxone administration was 
indicated. The participants were primarily male and the majority had witnessed an opioid 
overdose in the past. Results from the study found that individuals who were trained in 
OEND were more competent at recognizing overdose scenarios as well as identifying 
when Naloxone was indicated. Trained individuals scored 82.5% competency in 
recognizing overdose symptoms versus only 63% competency in the untrained 
individuals. Results also demonstrated that trained individuals were just as competent as 
trained medical professionals in recognizing overdose and when Naloxone was indicated. 
Both medical experts and trained individuals appropriately assigned approximately 45% 
of the scenarios to the opioid overdose category. 
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 Although research was not abundant, evidence has shown that implementing 
OEND programs can be effective in reducing harm and decreasing overdose related 
deaths. Individuals who received training were more informed and have increased 
knowledge, which provides further evidence for the implementation and continuation of 
the programs. Research did not differentiate amongst who were the most effective 
trainers, but with nurses being at the bedside, there was an increase in access to patients 
and their families, which provided ample opportunities for patient teaching. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Theoretical Framework 
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W.K. Kellogg’s Logic Model 
 This OEND: Train the Trainer program was developed using W.K. Kellogg 
Foundation’s program logic model. According the Logic Model Development Guide 
(2004), the logic model is “a conscious process that creates an explicit understanding of 
the challenges ahead, resources available, and the timetable in which to hit the target” 
(p.1). The model provided a visual guide for investors to understand what benefit will 
come from the program.  
          The model consisted of two main portions:  planned work and intended results. 
Within planned work, both resources and program activities were considered. Resources, 
or inputs, included manpower needed to implement the program, the time involved and 
cost of the time, financial investment placed, and the resources available within your 
organization. Planned activities consised of all of the tools and measures put into place to 
bring about change. Such actives include the “how” of your implementation. How will 
the desired effect come about? For example, what tools will you use and how will you 
present the material? (W.K. Kellogg Foundation, 2004). The second piece of the model 
involved examining the outputs from the planned activities. What came out of the 
planning stage? What are the outcomes and how did those outcomes make an impact? 
Figure 1 provides a visual diagram of how the model works from start to finish.  
 
Figure 1. 
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W. K. Foundation Basic Logic Model 
Following the definition of planned work and intended results, there are three 
main steps involved in developing a program: planning and design, implementation, and 
evaluation. Ideally, these three steps are a constantly evolving process utilized to 
continually improve the quality of the program. 
Knowles’ Theory of Adult Learning 
 The content development, or planned activities, of this program were constructed 
utilizing Knowles’ Theory of Adult Learning, a model of assumptions about learners 
(Knowles, 1970).  Knowles states that when teaching adults, the educator must account 
for the predisposing factors that the adult learner brings to the table. He addressed 
assumptions about the adult learner and uses those assumptions to make practice 
implications.  
 Knowles identified five practice implications that the teacher or educator must 
consider to effectively teach adult learners. The first issue that Knowles addressed was 
ensuring that the “learning climate” is conducive and comfortable for students. Students 
should be both physically comfortable in the environment, but they must also be 
psychologically at ease. The learning climate included the manner in which the educator 
presents himself as the adult learner is often dissuaded by judgment from other adults. 
Knowles also suggested that a “diagnosis of needs” be performed that involves defining 
the required competencies and allowing the learner to assess their knowledge both before 
and after the education takes place.  After the learners’ needs have been identified, the 
planning process should take place. Knowles stressed the importance of allowing learners 
to be involved in the process of their learning. The educator must then utilize the 
planning to promote learning. Educators must act more as resources than formal 
educators. Students should be self-directed in their learning. The final implication is self-
evaluation. Knowles stressed the importance of providing ways to allow the students to 
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evaluate their progress. He addressed the usefulness of the needs diagnosis in measuring 
learning progress (Knowles, 1970). 
 Both of these models were used to develop this program. The Logic Model was 
utilized in the planning stage, which will be described in more detail in the following 
section, and Knowles’ theory was considered when planning how to carry out the 
education. Because Knowles also stressed the importance of a needs assessment, a four 
phase needs assessment was also done.  
In order to appropriately identify educational needs of the RNs, the Four Phase 
Needs Assessment Model was followed. The goals focused on educating RNs on the 
epidemic of opioid overdose and increase RN knowledge base on OEND content. To 
determine whether the goals were being met or how well they were being met, a pre-
intervention survey (Appendix C) was performed. The next step of the needs assessment 
was to analyze the results of the pre-intervention survey and determine the gaps in 
knowledge. Percentages were used to determine how RNs scored on each particular 
question. The final phase of the educational needs assessment was to  set priorities of the 
teaching to occur. The data from the gap assessment was utilized to determine which 
content areas need more focus than others. The data helped to construct the content of the 
teaching and ensure that the educational goals were met. This phase also involved 
determining the consequences of the goals not being met and identifying the cost of the 
resources that were needed to meet the educational goals (SUNY, 2014). 
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Method 
Purpose 
 The purpose of this project was to develop and implement an educational program 
for registered nurses on the epidemic of opioid overdose and the safe administration of 
Naloxone by opioid addicts and their family members.  
Design 
 The design of this study consisted of a pre survey, intervention, post survey. Prior 
to the educational program being offered, a Survey Monkey® questionnaire was 
administered to participants. The survey was available for completion until the day before 
the education was offered. Participants who attended the educational program were then 
asked to complete an identical post-education questionnaire. 
Participants 
 Participants for this program were Registered Nurse employees of a 27 bed 
medical/surgical telemetry unit at the Veteran’s Affairs Medical Center. Ideally, the 
education was to reach at least 50% of the 27 Registered Nurse employed on the medical-
surgical floor. 
Site 
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 The site of this program development was the Providence Veteran’s Affairs 
Medical Center (PVAMC). The PVAMC is a small, academic medical setting treating 
Veterans of the United States Armed Forces. The site contains 77 acute care beds. 
Approval 
 Approval was obtained from the Institutional Review Board at the PVAMC as 
well as Rhode Island College. 
Planning 
Program Development: Logic Model 
 Logic Model/Planning and Needs Assessment. A needs assessment was 
conducted to establish evidence of the problem and determine educational needs of the 
registered nurses on the identified unit. Burton & Merrill (1991) identified four phases of 
a needs assessment. These four phases were to: list goals, determine whether or how well 
the goals are being achieved, determine gaps between desired and actual performance, 
and setting priorities.  
 The needs assessment began as the opioid overdose epidemic dramatically 
increased. Overdose numbers began to increase both locally and nationally. The increase 
in incidents prompted a local call for action. At the same time, the Veteran’s Health 
Administration (VHA) issued a directive for all VHA facilities to implement OEND 
programs to prevent opioid overdose deaths from occurring. The PVAMC proposed a 
pilot program to implement an OEND program within the Opiate Treatment Program 
(OTP). An informal committee consisting of the Chief of Primary Care, Chief of 
Pharmacy, OTP medical staff,  OTP Lead Nurse (this researcher), and Interventional Pain 
Clinic medical staff met to define the goals of the program and to determine the logistics 
of who would be eligible to receive a Naloxone Kit, who would be ordering the kits, who 
would be providing the education to patients, and how the program would expand past 
the pilot. A formal proposal was submitted to the Pharmacy and Therapeutics (P&T) 
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committee. The P&T committee addressed the logistics of ordering Naloxone rescue kits 
and further defined the process by which patients would be educated.  
 Once the pilot program was successfully initiated, the question arose as to 
whether similar programs would be beneficial in other services around the medical 
center. The VHA issued Interim Recommendations for the VA Overdose Education and 
Naloxone Distribution Program (Appendix A: OEND Interim Guidelines) (Department of 
Veterans Affairs, 2014). The recommendations highlighted populations that would 
benefit from OEND. Patients admitted for inpatient opiate withdrawal management were 
identified as a “direct association with benefit” population. The researcher, the Nursing 
Excellence and Evidence Based Practice Coordinator, the Performance Improvement 
Coordinator, and the Chief of the Health Information Management System worked 
together to identify the number of patients seen for withdrawal management in Fiscal 
Year 2013 (FY13). Patients were identified by isolating ICD-9 codes 304.00 opioid type 
dependence, unspecified. In FY13, the PVAMC treated 135 patients for opioid 
dependence on an inpatient basis. With this in mind, the team determined that there was a 
sufficient need to implement an OEND pilot program on one of the inpatient units. The 
program consisted of the researcher educating the Registered Nurses of an identified 
medical-surgical telemetry floor on the opioid overdose epidemic and the safe 
administration of Naloxone by patients and family members in the event that they witness 
an opioid overdose.   
Logic Model: Program Design and Planning  
 The content of this project was determined from the outcomes of the needs 
assessment, the review of the relevant literature, and the collaboration of the Chief of 
Nursing, the Nurse Excellence Coordinator, the Clinical Nurse Leader (CNL), the 
Medical/Surgical unit Nurse Manager, and the researcher.  
 The first steps of program design involved the planned work, which included 
identifying necessary resources, and planned activities. Resources identified were the 
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staff members needed to implement the program. All of the aforementioned staff 
members were considered resources for the project, but the researcher would be the 
individual to offer the education. Other resources included time devoted to the project, 
time given by the participants of the program, space to implement the project, necessary 
materials i.e. a trifold poster, paper, and computer access. Planned activities involved 
identifying the objectives of the program and how they would be met. The learning 
objectives of the program included understanding the opioid overdose epidemic, 
recognizing risk factors for opioid overdose, recognizing signs and symptoms of opioid 
overdose, understanding when and how to safely administer Naloxone, and the 
importance of accessing immediate medical attention in the case of witnessed overdose.  
 The content objectives were utilized to construct a PowerPoint program 
containing relevant information. The PowerPoint program included recent local and 
national opioid overdose statistics as well as visual aids to support those statistics. The 
program also included OEND materials that were already being used for patient 
education within the facility. The patient education materials included information on 
how to prevent opioid overdose, information about the medication Naloxone, how to 
recognize signs and symptoms of an overdose, and how to react in the case of a witnessed 
overdose. Participants were taught the acronym NARC 9-1-1 to remember the necessary 
steps to take in the event of a witnessed opioid overdose. NARC 9-1-1 stands for 
Naloxone, Airway, Rescue breathing, and Call 9-1-1. Each of those steps was elaborated 
upon to promote learning and understanding. All of the information was also reinforced 
on a trifold poster that was left in the conference room of the inpatient floor so that nurses 
could utilize the information as a refresher prior to providing patient education.  
Procedures 
Approval was first sought from the PVAMC administration. After receiving 
approval from the Nurse Excellence Coordinator and Nurse Executive, IRB approval was 
sought and obtained from both the Providence Veterans Affairs Medical Center and 
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Rhode Island College. Upon IRB approval, registered nurses on the designated medical-
surgical floor received an informational email (Appendix B: Informational Email) 
informing them of the project, the project timeframe, and asked for their participation in 
the pre and post surveys. Prior to the educational program being offered, a pre-
intervention survey (Appendix C: Pre-survey) of content knowledge was offered using 
Survey Monkey®. RNs were able to provide informed consent through the Survey 
Monkey® software.  
Intervention 
 A 20 minute educational class was provided to each of the three different shifts. 
The educational program consisted of a 20-minute teaching which was offered a total of 
three times. Educational sessions were held at 04:30, 11:00, and 19:00 in attempts to 
accommodate nurses working each shift. The program included a PowerPoint 
presentation educating participants on the epidemiology of opioid overdose, risk factors 
for opioid overdose, and OEND materials and procedure for patient education. Following 
the program, a post-intervention survey (Appendix C: Post-survey) was offered on 
Survey Monkey®. Educational brochures were left in the unit conference room to 
reinforce learning. The RNs were provided with the contact information of the OTP Lead 
RN in the case of further questions. The OTP Lead RN worked closely with the CNL to 
ensure that staff education remained up-to-date. 
Measurement 
 A survey was developed by Traci Green (2006) and was utilized and adapted, 
with her permission, for the purposes of this study. The Brief Overdose Recognition 
Response Assessment (BORRA) was originally developed for patients or individuals 
using opioids in the clinic setting. It has since been used to measure OEND training 
objectives for caregivers, prisoners, police and fire officials, and pharmacists. The survey 
offered sixteen different scenarios and asked the participant to answer either “Definitely 
or probably not an opiated OD,” “An OD but definitely NOT an opiate OD (for example, 
18	
 
cocaine intoxication),” ” “Not signs of an overdose,” or “Unsure/not enough info.” In 
each scenario, participants were also asked whether or not Naloxone should be 
administered.  Items were then scored with either a “1” or “0” depending on the 
appropriate answer. Correct answers were calculated out of 16 and divided to get a 
percentage correct, which would demonstrate overdose and naloxone administration 
knowledge.  
 The survey had historically been administered via pencil and paper, but was 
adapted into an electronic survey through Survey Monkey® (Appendix D: Brief 
Overdose Recognition Response Assessment). Registered Nurses employed on the 
designated floor were asked to participate in the survey, which they completed online. 
Both pre and post surveys were identical.  Adaptations from the original survey included 
removing the answer option “an overdose but definitely not an opiate overdose” as well 
as removing two of the redundant items, making this a fourteen item questionnaire. This 
particular program focused solely on the ability to recognize signs and symptoms of 
opioid overdose. It was unnecessary to be able to distinguish or recognize overdose of 
other substances. 
 Data was measured following the completion of the return of the post-intervention 
surveys. Means were calculated to determine whether RNs knowledge of OEND 
increased for each item in question. The difference in means provided insight into 
whether or not nurses gained knowledge on how to recognize signs of opioid overdose 
and whether or not to administer Naloxone.  
Time Frame 
Permission was first granted from the EBP Coordinator and Nurse Manager to 
implement the project.   IRB approval was obtained from the Providence VAMC in 
January 2015 and from Rhode Island College in March 2015. The SurveyMonkey® pre-
education questionnaire was rolled out on March 17, 2015. The pre-education 
questionnaire was open for a period of three months to allow for appropriate response 
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time. The educational sessions were offered during the last week of July. The post-
education questionnaire was offered the day after the education was completed and was 
open for approximately two weeks. Data analysis occurred during August and September. 
The results and final paper would be ready for presentation in December. 
Ethical Concerns 
  Potential ethical concerns for the project were that nurses are often considered a 
vulnerable population and therefore must be provided a higher level of protection. All 
participants gave informed consent prior to participating in the study. Another area of 
concern was the content of the education. Overdose Education and Naloxone Distribution 
is a harm reduction approach, which is often considered a controversial approach, 
however; the project only focused on educating nurses on how to provide the education. 
Participants did not include patients and/or family members of patients diagnosed with 
opioid abuse. 
Logic model: Program Evaluation 
 Following the completion of the project, program participants were given the 
opportunity to evaluate the program. A program evaluation tool (Appendix E: Program 
Evaluation) constructed by the VHA was utilized to assess if participants considered 
goals having been met. Questions were answered on a Likert-type scale. RNs were also 
provided with the opportunity to provide recommendations for change or identify 
strengths of the current program. 
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Results 
 Results from data analysis will be discussed in this section. 
Demographics  
 To protect anonymity in such a small learning facility, no specific demographic 
data were collected. There were 21 out of 27 (77%) potential participants who completed 
the pre-education questionnaire (pre-test) and 15 out of 27 (56%) who completed the 
post-education questionnaire (post-test). All participants were employed on the medical-
surgical floor.  
Pre/Post Survey Results 
 Prior to the education being offered, an email was sent out to the RNs employed 
on the floor where the project was taking place. The email provided a link to the pre-
education survey as well as dates and times that the education would be offered.  There 
were 21 RNs who participated in the pre-education survey. After the education was 
offered, RNs were provided a link to the post-survey. Out of the 21 original participants, 
15 RNs completed the post-education survey. Results were broken down into two 
categories: items containing scenarios consistent with symptoms of opioid overdose/ 
administer Naloxone and items inconsistent with opioid overdose/ do NOT administer 
Naloxone. Means were gathered from respondents for both the pre-test and post-tests for 
each item. Means were broken down both by individual question as well as overall 
difference in pre and post-test scores. For questions containing symptoms consistent with 
signs of opioid overdose mean scores improved from 69% to 84%, demonstrating an 
increase in knowledge gained. Means for questions containing symptoms inconsistent 
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with symptoms of opioid overdose demonstrated a decline in scores between the pre and 
posttests. Prior to the education being offered, 68% of respondents answered the 
questions correctly. After the education, only 63% of respondents answered questions 
correctly. Explanations for these changes are discussed in the following section. The 
following tables demonstrate the mean differences for each invidiual question. Table 1.1 
illustrates the results of the pre and post tests for items consistent with symptoms of 
opioid overdose and Table 1.2 illustrates the results for items inconsistent with symptoms 
of opioid overdose. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Results for items consistent with symptoms of opioid overdose 
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Table 2 Results for items inconsistent with symptoms of opioid overdose 
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Program Evaluation 
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A program evaluation was offered following the completion of the education. 
Participants had the opportunity to provide feedback on the education and any 
suggestions that they may have for improvement. A standard evaluation form measuring 
the objectives of the education were met and how well they were met as well as the 
effectiveness of the presenter, was offered to participants who completed both the pre and 
post questionnaires (Appendix F: Program Evaluation).  
The evaluation was broken down into two different sections. The first section was 
based on a 4-point Likert scale and asked participants to rate the effectiveness of the 
presenter in meeting the educational objectives. The second section, which was also 
based on a 4-point Likert scale with slightly different options than the first, asked 
participants to rate how well the speaker presented the information. In 3 out of 4 items in 
the first section, respondents answered “4- Completely met”. In the item “Describe the 
sources for Patient Education and identify notes required for documentation” one 
respondent answered “3- Mostly met.” Similar results were found in the second section of 
the evaluation. All respondents either answered “4-Excellent” or “3-Very good” for all 
five items. The results are displayed in the tables 3 and 4, which are found below. 
 
 
 
 
 
 
Table 3 Program Evaluation, Objectives Met 
Learning Objective Mean Score Completely Met              
(4) 
Mostly 
Met        
(3) 
Partially 
Met        
(2) 
Did 
Not 
Meet     
(1) 
Discuss the Epidemiology 
of Overdose. 
 
 
4.0 
 
15 
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0 
 
0 
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0% 
 
0% 
 
0% 
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Table 4 Program Evaluation, Presenter and Teaching Strategies 
Describe the eligibility for 
Naloxone kits. 
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	 Mean Score Excellent            (4) 
Very 
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Speaker’s expertise 
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&/or handouts were 
 
 
 
14 
 
1 
 
0 
 
0 
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Summary and Conclusions 
 Opioid overdose is defined as a condition caused by the ingestion or absorption of 
opioids (CDC, 2013).  Over-ingestion of the substance causes an individual’s respiratory 
drive to shut down leading to death by apnea and hypoxemia. The number of overdose 
deaths in the United States has been increasing over the past few years to the point of an 
epidemic. One method that clinicians have used to combat this epidemic is increasing 
access of addicts to the opioid overdose reversal agent, Naloxone. Access to Naloxone 
has been a somewhat controversial approach.  
 A literature review was performed to address the controversial nature of these 
programs and to demonstrate the effect that allowing access to Naloxone has had on the 
number of overdose-related deaths. Prescribing Naloxone to the opioid addict through 
available and supported 
the teaching   methods 
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Overdose Education and Naloxone Distribution (ONE) programs as a means to prevent 
overdose is an example of harm reduction. Harm reduction involves decriminalizing or 
reducing stigma to substance abuse without requiring abstinence. According to the 
literature, harm reduction has been an effective way to combat the number of fatalities 
from opioid overdose. OEND programs are typically offered by trained professionals and 
involve teaching persons addicted to opioids and/or their friends and family how to 
recognize signs and symptoms of opioid overdose and how to safely and appropriately 
administer the medication to reverse the overdose. Based on initial program evaluations, 
OEND has been successful in reducing the number of overdose-related deaths (Doe-
Simkins et al, 2014). An educational program, aimed at nurses working on a medical-
surgical telemetry floor, was developed using W.K. Kellogg’s Logic Model and 
Knowles’ Theory of Adult Learning. 
 The developed educational program was offered to all RNs working on the 
identified medical-surgical telemetry floor. There were a total of 21 participants. The 
questionnaire contained 14 scenarios and asked the participants to identify whether the 
scenario contained symptoms consistent with those of opioid overdose and whether or not 
they would administer Naloxone to the individual based on the symptoms in that 
particular scenario. The rationale for the program was that medical-surgical nurses would 
be better educated and more familiar with how to recognize signs and symptoms of 
overdose after the education than they were beforehand. This would allow these nurses to 
offer the education to patients and families prior to discharge from the inpatient setting as 
patients who have undergone opioid detoxification while inpatient are at a far greater risk 
for overdose upon discharge due to their tolerance being lowered. 
 Due to schedule conflicts and heavy workload, only 15 (71%) participants were 
able to attend the program. After completion, a link to the post-education survey was sent 
out to the participants with a one week timeline for completion. Emails reminders were 
sent out to participants mid-week and one day before the deadline.  
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After the post-education questionnaire responses were received, results were 
analyzed to determine whether the teaching had been effective. The scenarios were 
broken down into two different categories: items containing symptoms consistent with 
opioid overdose/ administer Naloxone and items containing symptoms inconsistent with 
opioid overdose/ do NOT administer Naloxone. Mean scores were measured for each 
item for both the pre and post questionnaires. Upon analyzing the data, two conclusions 
can be made. The first conclusion was that the education was successful in teaching 
participants how to recognize the signs and symptoms of opioid overdose. When the 
results were examined between the pre and post surveys, there was improvement in all 
but one of the scenarios in the first category for both recognizing symptoms of overdose 
and knowledge about whether or not to administer Naloxone for the associated 
symptoms. In pre-education surveys, overall means for these items showed that 71.38% 
of the respondents answered the questions correctly and in the post surveys 84% of the 
items were answered correctly. In item 12a with the following symptoms, “Very slow or 
shallow breathing or not breathing at all, convulsions (seizures), severe sweating or 
shakes, eyes: pinpoint pupils, eyes rolled back, blue nails, toenails or fingernails, very 
slow, faint pulse or no pulse at all, no response to shaking, calling their name, pain (deep 
sleep)” 95% of respondents initially identified this correctly, but in the post survey, only 
93% of respondents answered correctly. One explanation for this might be that 
convulsions or seizures were also taught as symptoms of cocaine overdose, which may 
have caused some confusion.  
The second conclusion that was made from analyzing the results was that more 
time should be spent educating RNs on symptoms specifically not consistent with opioid 
overdose. In the pre-education surveys, 46.5% of participants were able to correctly 
identify that these scenarios contained symptoms of other types of drug overdose. In the 
post surveys, the results were 46.6% correct. The bigger discrepancy in these items 
involved whether or not the participants felt that Naloxone should be administered. Before 
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the education, 90% of participants answered the questions correctly. Afterwards, 79.6% of 
respondents answered correctly. The explanation for this is most likely that a common 
question posed in each offered class was, “Is there any harm in administering Naloxone if 
the person is not experiencing an opioid overdose?” The general answer to this question 
was that there is no harm, which is what most likely influenced participants to be more 
liberal in administering Naloxone. 
Overall, the project met the objectives which were for RNs to be more familiar 
with the signs and symptoms of opioid overdose and feeling confident when to administer 
Naloxone. Being able to recognize signs and symptoms of other types of drug overdose is 
not necessary. Naloxone can be safely administered to an individual whether or not they 
are experiencing overdose.  
Limitations 
There were many limitations in the execution of this project. The first limitation 
identified was that the four surveys rolled out to the same population of nurses within a 
week of the pre-education surveys being rolled out. These surveys were lost in the mix 
and it was difficult to recruit more participants. The next limitation was the large number 
of nurses who took new positions between the rollout of the surveys and the education 
being offered. Due to scheduling conflicts, the education was offered nearly 4 months 
after the surveys were first rolled out. This reduced the number of participants available to 
complete the education and the post-surveys. Ideally, the education would have consisted 
of a PowerPoint in a  one hour time frame to appropriately deliver the information. 
Unfortunately, floor nurses do not have the time to dedicate to this type of learning and the 
program had to be delivered in a 20 minute timeframe.  
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Recommendations and Implications for Advanced Practice Nursing 
 While the program did not improve outcomes for both recognition of opioid 
overdose and need to administer Naloxone, the education was proven to be effective for 
the more important of the two, recognition. Consistent with the literature, the OEND 
program helped individuals more accurately recognize the signs and symptoms of opioid 
overdose.  
 Alternative teaching could have created an interactive, online learning module. 
That would allow nurses to complete the education at a time more convenient for them. It 
would also allow for learning materials to be stored in an electronic database so that 
nurses could more easily access them in the future. 
 The results from this project were disseminated to the nurse managers during the 
morning meeting. The nurse managers delivered the information to their staff during 
monthly staff meetings. Results were also provided to the members of the Nurse Practice 
Council during their monthly committee meeting for consideration of project expansion 
to other units. A poster presentation was offered during the medical center’s yearly 
Evidence Based Practice Conference. The project was  presented at Rhode Island 
College. 
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Appendix A 
OEND Interim Guidelines 
NALOXONE KITS AND NALOXONE AUTOINJECTORS 
Recommendations for Issuing Naloxone Kits and Naloxone Autoinjectors 
for the VA Overdose Education and Naloxone Distribution (OEND) Program  
October 2015 
VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives  
in collaboration with the VA OEND National Support and Development Work Group 
The following recommendations are based on medical evidence, clinician input, and expert opinion.  The content of the 
document is dynamic and will be revised as new information becomes available. Local adjudication should be used until 
updated guidance and/or CFU are developed by the National PBM. The purpose of this document is to assist practitioners 
in clinical decision-making, to standardize and improve the quality of patient care, and to promote cost-effective drug 
prescribing.  
The drug Product Information should be consulted for detailed prescribing information. Also see Naloxone Autoinjector 
Abbreviated Review at www.pbm.va.gov . 
 
The VA Overdose Education and Naloxone Distribution (OEND) program is a harm reduction and risk 
mitigation initiative that aims to decrease opioid-related overdose deaths among VA patients The issuance 
of naloxone kits or autoinjectors constitutes just one component of the OEND program; opioid overdose 
prevention, recognition of opioid overdose and rescue response comprise other key components. While 
anyone may be educated and trained in these aspects of opioid overdoses, naloxone remains a medication 
obtainable only by prescription in most states in the U.S. Naloxone kit and autoinjector utilization and rates 
of opioid overdose and mortality will be tracked nationally in VA to evaluate the OEND program’s 
performance. The PBM, MAP, and VPEs, in collaboration with the VA OEND National Support and 
Development Work Group, prepared the following recommendations to provide standardized guidance on 
the issuance of naloxone kits and autoinjectors under the VA OEND program. 
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CLINICAL RECOMMENDATIONS FOR OFFERING NALOXONE KITS AND NALOXONE 
AUTOINJECTORS 
A prescription is required for naloxone kits and naloxone autoinjectors. 
Discuss naloxone as an opioid harm reduction / risk mitigation option with patient and/or 
family/carer and document the discussion in the patient’s medical records.  
Offer naloxone kits to Veterans prescribed or using opioids who are at increased risk for opioid 
overdose or whose provider deems, based on their clinical judgment, that the Veteran has an 
indication for a naloxone kit. See examples of candidates for naloxone kits below. 
 
Offer naloxone autoinjectors to those who are candidates for naloxone kits AND are unable to 
demonstrate assembly and administration of the IM and IN ‘kit’ naloxone in a timely manner.  
 
Examples of Candidates for Naloxone Kits include but are not limited to Veterans with the following: 
• Opioid use disorder diagnosis  
• Prescription opioid misuse 
• Injection opioid use 
• Likely to have an opioid overdose such as individuals who receive VA or non-VA care in these 
situations: 
o Medication Assisted Treatment Program 
for opioid use disorder 
o Inpatient withdrawal management for 
opioid use disorder (particularly patients recently discharged from abstinence program) 
o HIV education / prevention program 
(which may provide care to injection opioid users) 
o Syringe access program  
o Outpatient and residential opioid use 
disorder treatment programs 
o Community meetings / Support group 
programs for opioid use disorder 
o Emergency departments (e.g., for opioid 
poisoning / overdose or intoxication) 
o Domiciliary care or community-based 
treatment for homeless Veterans 
o Primary health care (e.g., 
for follow-up of recent opioid poisoning / overdose or intoxication) 
Also refer to Error! Reference source not found. on page Error! Bookmark not defined. as a guide for 
evidence-based classification of OEND candidates. Error! Reference source not found. on page 
Error! Bookmark not defined. provides relative risks of opioid overdose deaths among Veterans 
prescribed opioids. 
 
Nonveterans requesting naloxone should be directed to community-based OEND programs. A national 
locator is available at http://hopeandrecovery.org/locations/ . 
 
Individuals in hospice / palliative care are likely NOT appropriate candidates for naloxone kits or 
autoinjectors. OEND should be considered on a case by case basis and not routinely in hospice / palliative 
care patients. 
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Assessment Tools for Risk of Opioid-related Serious Toxicity or Overdose 
• There are no published or fully validated tools available at this time that may be used to estimate 
patient risk for serious toxicity or overdose related to opioids.  
• The manufacturer of naloxone autoinjector, Kaléo, is developing a tool that intends to estimate the 
probability of serious toxicity or overdose based on an index score based on the presence of various 
risk factors in patients prescribed opioids. The investigators identified the risk factors and 
retrospectively validated the tool using VHA administrative data. 
• Guideline-concordant risk assessment tools for predicting opioid aberrant drug-related behavior or 
problematic substance use should be used as part of a comprehensive risk assessment of patients 
being treated for substance use disorders or chronic pain. These tools have not been shown to be 
useful for predicting opioid overdose; however, they may provide information that is important to 
consider in the overall risk assessment and management of the patient. 
 
Educate and train the patient on the proper use, storage, administration and disposal of naloxone 
kits and needles and autoinjectors.  
• Explain that naloxone combined with overdose education complement, but do not replace, safe and 
responsible opioid use.  
• Emphasize the importance of being familiar with naloxone administration technique before an 
emergency arises.  
• Advise the patient about the importance of friends, family members, partners, and carers being 
educated and trained on the proper use, potential harms and limitations of naloxone treatment. A list 
of resources for education and training is included in the naloxone kits. Patient education resources 
include the following: 
o SAMHSA Opioid Overdose Prevention Toolkit:  Contains safety advice for patients and resources for 
family members. http://store.samhsa.gov/product/Opioid-Overdose-Prevention-Toolkit/SMA13-4742  
o Community-Based Overdose Prevention and Naloxone Distribution Program Locator:  Identifies programs 
outside of the VA that distribute naloxone. http://hopeandrecovery.org/locations/  
o Prescribe to Prevent:  Patient resources and videos demonstrating overdose recognition and response, 
including naloxone administration.  • http://prescribetoprevent.org/video/  
• Optionally (but highly encouraged), also educate and train at least one patient-authorized 
acquaintance (i.e., one who is likely to witness opioid overdoses such as a friend, family member, 
partner or carer). 
• Instruct the patient to inspect the naloxone solution for particulate matter or discoloration, and check 
the expiration date. Avoid exposure of naloxone to prolonged temperature variations below 68° or 
above 77° F. For example, do not store naloxone in a vehicle subject to extreme high or low 
temperature changes. 
 
Issue a maximum of one naloxone kit (2 doses / kit) or autoinjector carton (2 doses / carton) per 
prescription. Prescriptions may be marked for one refill.  
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Naloxone Dosage and Administration  
 
 Intramuscular (IM) 
Naloxone Kit 
 Intranasal (IN) 
Naloxone Kit 
 IM / Subcutaneous Naloxone 
Autoinjector 
 • Inject 0.4 mg in 1 ml IM 
(using vials), through 
clothing if necessary 
• May repeat dose in 3–5 
minutes if no response 
• Dose may be repeated if 
apnea or hypopnea recurs 
 • Spray 1 mg in 1 ml in 
each nostril using 
atomizer device 
(each syringe 
contains 2 mg in 2 
ml) 
• May repeat dose in 
3–5 minutes if no 
response 
• Dose may be 
repeated if apnea or 
hypopnea recurs 
 • Administer 0.4 mg in 0.4 ml into the 
anterolateral aspect of the thigh, 
through clothing if necessary 
• May repeat doses every 2 to 3 
minutes (each carton  contains 2 
doses) 
 
Use requests to renew naloxone kit or autoinjector prescriptions as an opportunity to determine the 
circumstances (e.g., kit or autoinjector was used for overdose, lost, confiscated, expired, etc.) and 
base decisions to renew any prescriptions for opioids on the discussion with the patient and re-
assessment of risk-benefit.  
• Also use the discussion as an opportunity to engage the patient, re-assess risk-benefits, provide re-
education about overdoses, review Taking Opioids Responsibly (as applicable), consider opioid risk 
mitigation strategies, and modify treatment plans. 
 
To aid in national tracking of OEND program performance, providers should document opioid 
poisonings/overdoses in the medical record using the following ICD-10-CM code guidance: 
• Begin with DIAGNOSTIC CATEGORY T40, followed by a  
• 3 digit EXTERNAL CAUSE code, followed by a 
• 7th character DESCRIBING ENCOUNTER 
Because DIAGNOSTIC CATEGORY T40 denotes “Poisoning by, adverse effect of and underdosing of 
narcotics and psychodysleptics (hallucinogens)” broadly, it is important to use one of the opioid-related 3 
digit EXTERNAL CAUSE codes to allow documentation of the specific agent involved (if known) and 
whether the event was unintentional, intentional, an assault, undetermined, or due to an adverse effect. The 
7th character DESCRIBING ENCOUNTER are suffix letters A or D (initial or subsequent encounter, 
respectively) or S (sequela; a complication or condition arising from the overdose event). See the Table 
below for opioid-related 3 digit external cause codes to be tracked nationally.  
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Table 1. Three digit external cause codes (added to T40 Diagnostic category) for documentation/tracking of 
opioid poisonings/overdoses 
Poisoning by: Accidental 
(unintentional) 
Intentional 
self-harm 
Assault Undetermined Adverse 
effect 
Opium T40.0X1 T40.0X2 T40.0X3 T40.0X4 T40.0X5 
Heroin T40.1X1 T40.1X2 T40.1X3 T40.1X4 N/A 
Other opioids T40.2X1 T40.2X2 T40.2X3 T40.2X4 T40.2X5 
Methadone T40.3X1 T40.3X2 T40.3X3 T40.3X4 T40.3X5 
Other synthetic 
narcotics 
T40.4X1 T40.4X2 T40.4X3 T40.4X4 T40.4X5 
Unspecified 
narcotics 
T40.601 T40.602 T40.603 T40.604 T40.605 
Other 
narcotics 
T40.691 T40.692 T40.693 T40.694 T40.695 
 
 
 
Comparison of Kit and Autoinjector Routes of Administration  
 
Topic Intramuscular (IM) 
Naloxone 
 Intranasal (IN) 
Naloxone 
•  IM / SC Naloxone 
Autoinjector 
Onset • 2–3 min  • 2–3 min •  • Specific data not 
available 
Time to 
“Response”
†  
• Mean 6–8 min   • Similar or longer by 
2 min than IM 
• Mean 4.2 ± 2.7 
min; median 3 
minError! 
Bookmark not 
defined. 
• Range 2–13 min  
•  • Mean 6–8 minError! 
Bookmark not 
defined.,Error! 
Bookmark not 
defined.  
• Mean 9.6 ± 4.6 min 
(SC) 
Duration • Not well documented; 
longer than IV, which 
has a duration of 30 
min to 4 h 
• Dependent on amount, 
type and route of 
opioid 
 • Not well 
documented; see 
comments for IM 
naloxone 
•  • Not well documented; 
see comments for IM 
naloxone 
Advantages • Formulation 
manufactured for this 
route 
• Seems to have similar 
responder rates vs. IV 
naloxone in 
prehospital settings 
 • Reduces risk of 
blood-borne virus 
transmission in a 
high-risk population 
• Reduces risk of 
needlestick injuries 
• Obviates need for 
•  • Pocket-size; 
convenient; portable 
• Shown to be relatively 
easy to use even 
without prior training in 
English-speaking 
individuals (adults took 
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• Involves fewer steps to 
assemble  
• Simpler for some 
people (e.g., those 
familiar with using 
injections) 
needle disposal 
• Easy access to 
nares 
• May be preferred 
by people with 
aversion to needles 
or injections 
on average about 60 
sec (range, 30–160 
sec) to administer 
simulated injections. 
• Retractable needle may 
reduce accidental 
needle sticks and risk 
of blood-borne virus 
transmission in a high-
risk population 
• The needle is not seen 
before, during or after 
the injection; this may 
be a desirable feature 
for persons who have 
an aversion to the sight 
of needles. 
• Discourages re-use of 
the device by injection 
drug users. 
• The auto-injector 
cannot be opened by 
hand and modified; 
opening it by using a 
tool is difficult and 
renders it 
nonfunctional. 
• Can be stored in a 
wider temperature 
range 
• The auto-injector case 
provides adequate 
protection from light 
Disadvantages • Risk of blood-borne 
virus transmission 
(e.g., HIV, HBC, HCV) 
• Risk of needlestick 
injuries 
• Risk of injury from 
improper injection 
technique  
• Proper use requires 
competence in 
techniques for 
extraction of drug from 
vial and injection  
• Requires adequate 
muscle mass 
 • May have lower 
bioavailability vs. 
IM route 
• SimilarError! 
Bookmark not 
defined. or 
slowerError! 
Bookmark not 
defined. onsets. 
IM route 
• Similar or slightly 
lower responder 
rates vs. IM 
naloxone 
• May be more likely 
to require 
supplemental 
doses of 
naloxoneError! 
Bookmark not 
defined. 
• Not manufactured 
in a formulation for 
this route (the 
injectable form is 
aerosolized) 
• Nasal 
abnormalities (e.g., 
•  • If the voice instructions 
fail, persons with poor 
vision may have 
difficulty reading the 
label instructions 
because of the small 
font size 
• Restriction to IM or SC 
route of administration 
• Needle length in 
children less than 1 
year old; the skin 
should be pinched to 
prevent the needle from 
contacting bone. If the 
needle strikes bone, the 
needle may be broken 
or damaged and 
delivery of drug may be 
obstructed. 
• Lack of field testing by 
Overdose Education 
and Naloxone 
Distribution (OEND) 
programs. 
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epistaxis, trauma, 
deformity, mucous) 
and prior intranasal 
drug use may 
reduce 
effectivenessError! 
Bookmark not 
defined. 
• Involves more 
steps to assemble 
Other 
Considerati
ons 
• More common in U.S. 
naloxone programs 
• Carpujects are a 
potentially less costly 
alternative to vials; 
however, anecdotal 
reports suggest that 
the carpujects are 
more difficult to 
assemble, prices 
fluctuate, and 
carpujects have not 
been field-tested. 
 • Off-label use; very 
low-quality 
evidence that IN 
and IV/IM are 
similar in clinical 
effects 
• Associated with 
successful opioid 
overdose reversals 
using 1 mg/ml per 
naris (total 2 mg/2 
ml) and 2 mg/ml 
(experimental). 
• Extent of nasal 
absorption is 
dependent on 
mucosal surface 
area coverage, 
which is optimized 
by using an 
atomizer and 
limiting quantity to 
1 ml per naris. 
•  • The 4-year battery life 
for the voice 
instructions exceeds 
the product expiration. 
• Whether training is 
required in non-English 
speaking individuals 
has not been 
evaluated; FDA 
required human factor 
testing in English 
speaking individuals.. 
Disposal of 
Used or 
Expired 
Product 
• Biohazard sharps 
container 
 • Biohazard waste 
container 
•  • Biohazard sharps 
container 
† “Response” was defined in various ways (respiratory rate [RR] >10; increase in RR or Glasgow Coma Scale >6; return 
of spontaneous respiration; or “a significant improvement in consciousness”) or not defined in the studies. 
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Appendix B 
 Information Email 
Hello 6B nurses! 
 
I am going to be bringing Opioid Overdose Education and Naloxone Distribution to 6B in 
the very near future. I am doing this as a part of my Master’s thesis, so before providing 
you all with the education, I am going to ask each of you to fill out a pre-education 
survey: 
 
Pre Education Survey Link 
https://www.surveymonkey.com/r/JJHRQPK 
 
It will only take a few minutes and it will help me gauge the educational needs of the 
unit. I will be asking you to fill out a post-education survey as well in a few weeks. 
 
I would also like to ask if anyone would be interested in participating as a champion for 
this project. This would involve becoming a “trainer” for your peers who may not be able 
to attend the educational session I am giving and also assisting nurses who may have 
questions when they begin to utilize their training. (It also is a nice way to beef up your 
proficiencies.) Please email me if you are interested in this opportunity. 
 
I will be visiting the units on the different shifts to try and recruit champions as well as 
survey responses. Thank you all for the incredible care you give our Veterans. I look 
forward to working with you soon! 
 
Emily Daniell, BSN RN 
Lead Nurse, Opiate Treatment Program 
Providence VA Medical Center 
401-273-7100 x5824 
Appendix C	
Submitted as both Pre Survey and Post Survey 
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Appendix D 
Adapted Brief Overdose and Recognition Response Assessment 
	
Scenario	
	
Imagine	that	you	have	received	a	phone	call	from	a	patient’s	family	member.	The	
family	member	provides	you	with	the	following	symptoms	and	wonders	if	the	
symptoms	are	consistent	with	opiate	overdose.	Is	the	family	member	witnessing	an	
opiate	overdose?	Should	the	witness	 administer	Naloxone?	
	
Please	do	this	BY	YOURSELF.	 There	are	14	scenarios	asking	the	same	2	questions.	
	
Choose	only	ONE	answer	for	each	question.	
	
Scenario	1	 	
	
	
- Very	slow	or	shallow	breathing	or	
not	 breathing	at	all	
- Very	slow,	faint	pulse	or	no	pulse	at	all	
- Fell	unconscious	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	2	 	
- Very	slow	or	shallow	breathing	or	
not	 breathing	at	all	
- Blue	lips,	toenails	or	fingernails	
- Eyes:	pin	point	pupils,	eyes	rolled	back	
- No	response	to	shaking,	calling	their	
name,	 pain	(deep	sleep)	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	3	 	
	
	
-	Restlessness,	fidgety	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
54	
	
 
	 Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	4	 	
 
 
- Numbness;	couldn’t	feel	anything	
- Couldn’t	hear	anything	
- Felt	weak	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	5	 	
 
 
 
- Convulsions	(seizures)	
- Diminished	vision	
- Dizziness;	confusion	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	6	 	
 
 
 
 
-	Severe	sweating	or	shakes	
- Yawning	
- Goose	bumps	
- Muscle	pain/joint	aches	
	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	7	 	
 
 
- Eyes:	pinpoints	pupils,	eyes	rolled	back	
- Couldn’t	speak	
- Lost	their	voice	
- Black	out;	fainted;	unconscious	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	8	 	
- Blue	lips,	toenails	or	fingertips	
- No	response	to	shaking,	calling	
their	name,	 pain	(deep	sleep)	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
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	 ! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	9	 	
- Very	slow	or	shallow	
breathing	or	not	 breathing	
at	all	
- Eyes:	pinpoints	pupils,	eyes	rolled	back	
- Very	slow,	faint	pulse	or	no	pulse	at	all	
- Severe	sweating	or	shakes	
- No	response	to	shaking,	calling	
their	name,	 pain	(deep	sleep)	
- Blackout	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	10	 	
 
 
 
 
 
-	Heart	racing	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	11	 	
 
 
- Very	slow	or	shallow	
breathing	or	not	 breathing	
at	all	
- Very	slow,	faint	pulse	of	no	pulse	at	all	
- Vomiting	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
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Scenario	12	 	
- Very	slow	or	shallow	
breathing	or	not	 breathing	at	
all	
- Convulsions	(seizures)	
- Severe	sweating	or	shakes	
- Eyes:	pinpoint	pupils,	eyes	rolled	back	
- Blue	nails,	toenails	or	fingernails	
- Very	Slow,	faint	pulse	or	no	pulse	at	all	
- No	response	to	shaking,	calling	their	
name,	 pain	(deep	sleep)	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	13	 	
 
 
 
- Convulsions	(seizures)	
- Fear	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
Scenario	14	 	
 
 
- Very	slow	or	shallow	
breathing	or	not	 breathing	at	
all	
- Very	slow,	faint	pulse	or	no	pulse	at	all	
Are	the	symptoms:	
! Consistent	with	signs	of	an	opiate	OD	
! Not	signs	of	an	OD	
! Unsure/not	enough	info	
Do	these	symptoms	suggest:	
! Administer	Naloxone	
! Do	NOT	administer	Naloxone	
	
	
• Based	upon	the	Brief	Overdose	Recognition	Response	Assessment	and	adapted	for	this	
project	with	the	permission	of	author	Traci	Green,	PhD	
	
	
	
	
	
	
	
	
	
	
	
57	
	
Appendix E 
Program Evalutation	
 
Title:
  
Opioid Overdose Education and Naloxone Distribution 
Date:     
INSTRUCTIONS: This evaluation form must be completed and submitted at the end of 
the session.  
Learner’s Achievement of Each Objective Completely 
Met 
4 
Mostly 
Met 
3 
Partially 
Met 
2 
Not 
Met 
1 
Discuss the Epidemiology of Overdose.     
Describe the eligibility for Naloxone kits.     
Explain the process for order and prescriptions.     
Describe the sources for Patient Education and 
identify notes required for documentation. 
    
     
How will the information provided be used to enhance or change your practice?  BE 
SPECIFIC!  
Rate the teaching expertise of each presenter. 
            
 Presenter’s Name: E. Daniell 
Excellen
t 
     4 
Very 
Good 
    3 
Satisfactor
y 
         2 
Poor 
   1 
Speaker’s expertise contributed to the accomplishment of 
the learning objectives 
    
Teaching strategies/learning methods were utilized 
effectively 
    
Instructional materials &/or handouts were available and 
supported the teaching   methods    
    
Information updated me in my current practice     
The content & objectives are appropriate and relevant to 
your practice. 
    
          
Please rate your overall satisfaction with this program. 
 
4   Excellent  "     3   Very Good  "          2   Satisfactory"      1   Poor "  
      	
